AIIMS, Delhi to start second dose trial of COVAXIN on 2-6 years old children : Reports

WHO approves Covaxin ,Covaxin For Children, covaxin deal covaxin phase 3 trial, covaxin phase 3 analysis, PIL against Covaxin trial, Fights Indian Strain, Covaxin Phase I Trial Results: Vaccine Induced Antibody And Showed No Serious Side Effects, Covaxin trials for children, covaxin children, UK canada covaxin
Covaxin Children Trials: All India Institute of Medical Sciences (AIIMS) will start second dose trial of Covaxin on 2-6 years old children by next week as per early reports. AIIMS is the hub for trials of the India-made COVID vaccine for children below 18 years of age.

AIIMS has decided to begin the second dose trial of Covaxin reported The Mint. The vaccine, produced by Bharat Biotech for COVID, will now be tried upon for children aged 2-6 years.

The trials have already been underway for slightly older children in the age bracket of 6 to 12 years.

Globally a third wave is being predicted along with stronger COVID variants to emerge. In India too expectations are that the third wave will come by end of August, early September. The vaccine trials are in anticipation of these and reports say that vaccines for kids may be available as early as September.

This is a developing story